Manganese/cerium nanoferrites: Synthesis and toxicological effects by intraperitoneal administration in rats

Zn and Co ferrite nanoparticles: towards the applications of sensing and adsorption studies

An important deliberation of this current work is the impending applications of bivalent transition metals doped with nano ferrites and to study their emerging properties of magnetically active ferrites, which constitute oxides of iron (different conformers most demanding γ-Fe₂O₃) and transition metal complexes of bivalent metal oxides like cobalt (Co(II)) and magnesium (Mg(II)). Fe³⁺ ions occupy tetrahedral sites; the rest of Fe³⁺ and the Co²⁺ ions occupy octahedral sites. For the synthesis, a self-propagating method of combustion at lower temperature was used. Zinc and cobalt nano ferrites are synthesized from the chemical coprecipitation method of 20 to 90 nm in average size, characterized thoroughly employing FTIR and PXRD and surface morphology studied using SEM. These results explain the existence of ferrite nanoparticles in cubic spinel. Magnetically active metal oxide nanoparticles are now commonly employed in main studies of sensing, absorption, and other properties. All studies showed the interesting results.

Biosynthesis of phyto functionalized cerium oxide nanoparticles mediated from Scoparia dulsis L. for appraisal of anti-cancer potential against adenocarcinomic lung cancer cells and paracetamol sensing potentiality

This research work aims at the eco-friendly preparation of cerium oxide nanoparticles (CeSD NPs) utilizing the natural extract of Scoparia dulsis L. An attempt was made to analyze the influence of the fuel load on the size, shape, and optical properties of the nanoparticles. The p-XRD studies revealed the controlled formation of NPs with a size not more than 12.74 nm. The surface area studies appraise the mesoporous nature of the synthesized ceria particles, with the maximum specific surface area of 36.06 m²g^-1. The nano-regime CeO₂ nanoparticles had a definite impact on biomedical and electrochemical studies. The CeSD NPs with minuscule size (10.69 nm) manifested promising antioxidant and human RBC protection activity. The antioxidant properties were evaluated using % DPPH inhibition with of maximum of 83.38. The stabilization of RBC's by CeSD NPs was maximum at 94.97%. However, the CeSD NPs with apparent size (12.74 nm) that utilized greater volume fuel (25 mL) had noticeable results on adenocarcinomic lung (A549) cancer cell viability and antidiabetic study which was maximum of 70.16% at concentration 500 μg/mL. A satisfactory antibacterial application was proffered against chosen bacterial stains. The smallest size CeO₂ NPs exhibited the best proton diffusion coefficient (8.16 × 10^-6 cm²s^-1), and the capacitance values of the CeSD NPs are near in all samples (~ 1.17 to 2.00 F) manifest their compact nano-regime sizes. The paracetamol drug was chosen as analyte to appreciating the superlative efficiency for sensing paracetamol drug with the lowest detection limit.

Nanomaterials in the Management of Gram-Negative Bacterial Infections

The exploration of multiplexed bacterial virulence factors is a major problem in the early stages of Escherichia coli infection therapy. Traditional methods for detecting Escherichia coli (E. coli), such as serological experiments, immunoassays, polymerase chain reaction, and isothermal microcalorimetry have some drawbacks. As a result, detecting E. coli in a timely, cost-effective, and sensitive manner is critical for various areas of human safety and health. Intelligent devices based on nanotechnology are paving the way for fast and early detection of E. coli at the point of care. Due to their specific optical, magnetic, and electrical capabilities, nanostructures can play an important role in bacterial sensors. Another one of the applications involved use of nanomaterials in fighting microbial infections, including E. coli mediated infections. Various types of nanomaterials, either used directly as an antibacterial agent such as metallic nanoparticles (NPs) (silver, gold, zinc, etc.), or as a nanocarrier to deliver and target the antibiotic to the E. coli and its infected area. Among different types, polymeric NPs, lipidic nanocarriers, metallic nanocarriers, nanomicelles, nanoemulsion/ nanosuspension, dendrimers, graphene, etc. proved to be effective vehicles to deliver the drug in a controlled fashion at the targeted site with lower off-site drug leakage and side effects.

Active Targeted Nanoparticles for Delivery of Poly(ADP-ribose) Polymerase (PARP) Inhibitors: A Preliminary Review

Nanotechnology has revolutionized novel drug delivery strategies through establishing nanoscale drug carriers, such as niosomes, liposomes, nanomicelles, dendrimers, polymeric micelles, and nanoparticles (NPs). Owing to their desirable cancer-targeting efficacy and controlled release, these nanotherapeutic modalities are broadly used in clinics to improve the efficacy of small-molecule inhibitors. Poly(ADP-ribose) polymerase (PARP) family members engage in various intracellular processes, including DNA repair, gene transcription, signal transduction, cell cycle regulation, cell division, and antioxidant response. PARP inhibitors are synthetic small-molecules that have emerged as one of the most successful innovative strategies for targeted therapy in cancer cells harboring mutations in DNA repair genes. Despite these advances, drug resistance and unwanted side effects are two significant drawbacks to using PARP inhibitors in the clinic. Recently, the development of practical nanotechnology-based drug delivery systems has tremendously improved the efficacy of PARP inhibitors. NPs can specifically accumulate in the leaky vasculature of the tumor and cancer cells and release the chemotherapeutic moiety in the tumor microenvironment. On the contrary, NPs are usually unable to permeate across the body's normal organs and tissues; hence the toxicity is zero to none. NPs can modify the release of encapsulated drugs based on the composition of the coating substance. Delivering PARP inhibitors without modulation often leads to the toxic effect; therefore, a delivery vehicle is essential to encapsulate them. Various nanocarriers have been exploited to deliver PARP inhibitors in different cancers. Through this review, we hope to cast light on the most innovative advances in applying PARP inhibitors for therapeutic purposes.

Simulation, In Vitro, and In Vivo Cytotoxicity Assessments of Methotrexate-Loaded pH-Responsive Nanocarriers

In this study, pH-responsive niosomal methotrexate (MTX) modified with ergosterol was prepared for potential anticancer application. The prepared formulation had a size of 176.7 ± 3.4 nm, zeta potential of −31.5 ± 2.6 mV, EE% of 76.9 ± 2.5%, and a pH-responsive behavior in two different pHs (5.4 and 7.4). In-silico evaluations showed that MTX intended to make a strong hydrogen bond with Span 60 compartments involving N2 and O4 atoms in glutamic acid and N7 atom in pteridine ring moieties, respectively. The cytotoxic effects of free and pH-MTX/Nio were assessed against MCF7 and HUVECs. Compared with free MTX, we found significantly lower IC50s when MCF7 cells were treated with niosomal MTX (84.03 vs. 9.464 µg/mL after 48 h, respectively). Moreover, lower cell killing activity was observed for this formulation in normal cells. The pH-MTX/Nio exhibited a set of morphological changes in MCF7 cells observed during cell death. In-vivo results demonstrated that intraperitoneal administration of free MTX (2 mg/kg) after six weeks caused a significant increase in serum blood urea nitrogen (BUN), serum creatinine, and serum malondialdehyde (MDA) levels of rats compared to the normal control rats. Treatment with 2 and 4 mg/kg doses of pH-MTX/Nio significantly increased serum BUN, serum creatinine, and serum lipid peroxidation. Still, the safety profile of such formulations in healthy cells/tissues should be further investigated.